about
The impact of thyroid hormones on patients with hepatocellular carcinoma.Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy.Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2.Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure?Review article: systemic treatment of hepatocellular carcinomaTreatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinomaLetter: programmed cell death protein-1-targeted immunotherapy for advanced hepatocellular carcinoma-authors' replyImpact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertensionProgrammed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohortLetter: programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort-more questions than answers. Authors' replyNon-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different etiologies of advanced chronic liver diseaseSequential systemic treatment in patients with hepatocellular carcinomaSynthesis and Cytotoxic Activity of Chiral Sulfonamides Based on the 2-Azabicycloalkane Skeleton
P50
Q41237536-8F1C6DC9-E0DC-47D2-8FCF-20B3A507BFC4Q47863448-0F9B48D8-12C8-45ED-AF42-57DF1C4D62A4Q52655425-32976042-F2B7-446B-857D-C54294103DF6Q58704728-224F1172-F523-4659-9CE4-BBC7414382FDQ90436245-C2C74701-EDD5-4B42-BB00-EC4C8E8BC544Q91135279-F3FB0F32-F816-45CE-9B6B-BCD76DF1D4E3Q91948395-951A6490-289D-42BF-B344-2A5C3ECE9681Q92845305-5E840373-FD13-47C4-8BE3-0DACEC051D13Q93068290-FC2F31D5-88F5-4E00-84D5-BAACC8ABCB5BQ93072046-E18E83B5-D08C-4038-A1C4-0CBB42EA74C3Q94485784-16D76598-6FC8-463C-BCF6-B2E316170A64Q95310123-8C0BA230-CCFA-4C13-9C59-43F76887A306Q95655747-952C6974-B727-4AAA-A8A6-BD0E187884FE
P50
description
researcher ORCID ID = 0000-0002-7260-532X
@en
name
Matthias Pinter
@ast
Matthias Pinter
@en
Matthias Pinter
@es
Matthias Pinter
@nl
type
label
Matthias Pinter
@ast
Matthias Pinter
@en
Matthias Pinter
@es
Matthias Pinter
@nl
prefLabel
Matthias Pinter
@ast
Matthias Pinter
@en
Matthias Pinter
@es
Matthias Pinter
@nl
P21
P31
P496
0000-0002-7260-532X